Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy

Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy

Abstract Selective serotonin reuptake inhibitors (SSRIs) and internet-based cognitive behavioral therapy (ICBT) are recommended treatments of social anxiety disorder (SAD), and often combined, but their effects on monoaminergic signaling are not well understood. In this multi-tracer positron emissio...

Full description

Bibliographic Details
Main Authors: Olof Hjorth, Andreas Frick, Malin Gingnell, Jonas Engman, Johannes Björkstrand, Vanda Faria, Iman Alaie, Per Carlbring, Gerhard Andersson, My Jonasson, Mark Lubberink, Gunnar Antoni, Margareta Reis, Kurt Wahlstedt, Mats Fredrikson, Tomas Furmark
Format: Article
Language:English
Published: Nature Publishing Group 2022-10-01
Series:Translational Psychiatry
Online Access:https://doi.org/10.1038/s41398-022-02187-3

Internet

https://doi.org/10.1038/s41398-022-02187-3

Similar Items